228 related articles for article (PubMed ID: 22830352)
41. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D
J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200
[TBL] [Abstract][Full Text] [Related]
42. PKCtheta: A potential therapeutic target for T-cell-mediated diseases.
Chaudhary D; Kasaian M
Curr Opin Investig Drugs; 2006 May; 7(5):432-7. PubMed ID: 16729719
[TBL] [Abstract][Full Text] [Related]
43. Engagement of protein kinase C-theta in interferon signaling in T-cells.
Srivastava KK; Batra S; Sassano A; Li Y; Majchrzak B; Kiyokawa H; Altman A; Fish EN; Platanias LC
J Biol Chem; 2004 Jul; 279(29):29911-20. PubMed ID: 15150272
[TBL] [Abstract][Full Text] [Related]
44. A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.
Manicassamy S; Yin D; Zhang Z; Molinero LL; Alegre ML; Sun Z
J Immunol; 2008 Jul; 181(1):513-20. PubMed ID: 18566417
[TBL] [Abstract][Full Text] [Related]
45. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
Khoshnan A; Bae D; Tindell CA; Nel AE
J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
[TBL] [Abstract][Full Text] [Related]
46. Protein kinase C-theta critically regulates the proliferation and survival of pathogen-specific T cells in murine listeriosis.
Sakowicz-Burkiewicz M; Nishanth G; Helmuth U; Drögemüller K; Busch DH; Utermöhlen O; Naumann M; Deckert M; Schlüter D
J Immunol; 2008 Apr; 180(8):5601-12. PubMed ID: 18390745
[TBL] [Abstract][Full Text] [Related]
47. Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation.
Bi K; Tanaka Y; Coudronniere N; Sugie K; Hong S; van Stipdonk MJ; Altman A
Nat Immunol; 2001 Jun; 2(6):556-63. PubMed ID: 11376344
[TBL] [Abstract][Full Text] [Related]
48. PKC inhibitors: potential in T cell-dependent immune diseases.
Baier G; Wagner J
Curr Opin Cell Biol; 2009 Apr; 21(2):262-7. PubMed ID: 19195860
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
50. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C.
Villalba M; Bi K; Hu J; Altman Y; Bushway P; Reits E; Neefjes J; Baier G; Abraham RT; Altman A
J Cell Biol; 2002 Apr; 157(2):253-63. PubMed ID: 11956228
[TBL] [Abstract][Full Text] [Related]
51. PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo.
Gruber T; Hermann-Kleiter N; Pfeifhofer-Obermair C; Lutz-Nicoladoni C; Thuille N; Letschka T; Barsig J; Baudler M; Li J; Metzler B; Nüsslein-Hildesheim B; Wagner J; Leitges M; Baier G
Mol Immunol; 2009 Jun; 46(10):2071-9. PubMed ID: 19356803
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
53. Protein kinase C-theta (PKCtheta): it's all about location, location, location.
Altman A; Villalba M
Immunol Rev; 2003 Apr; 192():53-63. PubMed ID: 12670395
[TBL] [Abstract][Full Text] [Related]
54. Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.
Payvandi F; Wu L; Naziruddin SD; Haley M; Parton A; Schafer PH; Chen RS; Muller GW; Hughes CC; Stirling DI
J Interferon Cytokine Res; 2005 Oct; 25(10):604-16. PubMed ID: 16241859
[TBL] [Abstract][Full Text] [Related]
55. Protein kinase C-θ promotes Th17 differentiation via upregulation of Stat3.
Kwon MJ; Ma J; Ding Y; Wang R; Sun Z
J Immunol; 2012 Jun; 188(12):5887-97. PubMed ID: 22586032
[TBL] [Abstract][Full Text] [Related]
56. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes.
Werlen G; Jacinto E; Xia Y; Karin M
EMBO J; 1998 Jun; 17(11):3101-11. PubMed ID: 9606192
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence.
Pietromonaco SF; Simons PC; Altman A; Elias L
J Biol Chem; 1998 Mar; 273(13):7594-603. PubMed ID: 9516463
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase C-theta;: signaling from the center of the T-cell synapse.
Arendt CW; Albrecht B; Soos TJ; Littman DR
Curr Opin Immunol; 2002 Jun; 14(3):323-30. PubMed ID: 11973130
[TBL] [Abstract][Full Text] [Related]
59. eNOS S-nitrosylates β-actin on Cys374 and regulates PKC-θ at the immune synapse by impairing actin binding to profilin-1.
García-Ortiz A; Martín-Cofreces NB; Ibiza S; Ortega Á; Izquierdo-Álvarez A; Trullo A; Victor VM; Calvo E; Sot B; Martínez-Ruiz A; Vázquez J; Sánchez-Madrid F; Serrador JM
PLoS Biol; 2017 Apr; 15(4):e2000653. PubMed ID: 28394935
[TBL] [Abstract][Full Text] [Related]
60. PKC-θ is a negative regulator of TRAIL-induced and FADD-mediated apoptotic spectrin aggregation.
Michalczyk I; Toporkiewicz M; Dubielecka PM; Chorzalska A; Sikorski AF
Folia Histochem Cytobiol; 2016; 54(1):1-13. PubMed ID: 27094638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
